General InformationDeep Longevity is an AI-driven biological age assessment and longevity platform based in New York, founded in 2019, with approximately 20-40 employees.
Funding & FinancialsThe company has raised approximately $8-10 million across seed and Series A rounds, with backing from longevity-focused venture firms and strategic investors in the aging and biotech space.
Leadership & TeamFounded by Unlocking Longevity team members including executives with backgrounds in machine learning, gerontology, and computational biology, though specific CEO details require current verification.
Recent ActivityThe company has been advancing its deep learning models for epigenetic age prediction and expanding partnerships with pharmaceutical and research institutions for aging biomarker discovery and validation.